These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22043283)

  • 1. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases.
    Kim TW; Moon Y; Kim K; Lee JE; Koh HC; Rhyu IJ; Kim H; Sun W
    PLoS One; 2011; 6(10):e25346. PubMed ID: 22043283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease.
    Qiao C; Zhang LX; Sun XY; Ding JH; Lu M; Hu G
    Mol Neurobiol; 2017 Aug; 54(6):4292-4302. PubMed ID: 27339879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
    Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
    Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
    PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
    J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats.
    Ma C; Pan Y; Yang Z; Meng Z; Sun R; Wang T; Fei Y; Fan W
    Life Sci; 2016 Jan; 144():113-20. PubMed ID: 26612350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
    Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
    J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Zn
    Tamano H; Nishio R; Morioka H; Takeda A
    Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
    J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration.
    Oh CK; Han BS; Choi WS; Youdim MB; Oh YJ
    Apoptosis; 2011 Nov; 16(11):1087-100. PubMed ID: 21739275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.
    Wang Y; Qu L; Wang XL; Gao L; Li ZZ; Gao GD; Yang Q
    Mol Neurobiol; 2015 Feb; 51(1):424-36. PubMed ID: 24841382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease.
    Sophiabadi M; Rastgoo N; Haghdoost-Yazdi H
    Biol Trace Elem Res; 2022 Sep; 200(9):4058-4067. PubMed ID: 34741694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptide mimetic of BDNF ameliorates motor dysfunction and striatal apoptosis in 6-OHDA-induced Parkinson's rat model: Considering Akt and MAPKs signaling.
    Firouzan B; Iravanpour F; Abbaszadeh F; Akparov V; Zaringhalam J; Ghasemi R; Maghsoudi N
    Behav Brain Res; 2023 Aug; 452():114585. PubMed ID: 37467964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson's disease patients.
    Burguillos MA; Hajji N; Englund E; Persson A; Cenci AM; Machado A; Cano J; Joseph B; Venero JL
    Neurobiol Dis; 2011 Jan; 41(1):177-88. PubMed ID: 20850531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
    Chi H; Guan Y; Li F; Chen Z
    Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease.
    Kostrzewa RM
    J Neural Transm (Vienna); 2022 Jun; 129(5-6):445-461. PubMed ID: 35279767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.
    Kramer BC; Mytilineou C
    J Neurocytol; 2004 Mar; 33(2):213-23. PubMed ID: 15322379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration.
    Kim J; Jang S; Choi M; Chung S; Choe Y; Choe HK; Son GH; Rhee K; Kim K
    Mol Cells; 2018 Aug; 41(8):742-752. PubMed ID: 30078232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.